Just as delays in transmitting information about a drug’s safety can lead to poorly informed medical decisions, the same phenomenon applies when it comes to information about a drug’s effectiveness.Click here to access the article.
Friday, May 09, 2008
Misuse, overuse, underuse...
Check out "A Good Framework for Distributing Information About Off-Label Uses" written by Scott Gottlieb, M.D. and published on the American Enterprise for Public Policy Research's website; an excerpt: